624 related articles for article (PubMed ID: 23731843)
21. Prognostic factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): what's better?
Milione M
Endocrine; 2018 Jan; 59(1):1-3. PubMed ID: 28417314
[No Abstract] [Full Text] [Related]
22. Gastroenteropancreatic neuroendocrine tumors: current perspectives and future challenges.
Garcia-Carbonero R
Cancer Metastasis Rev; 2014 Mar; 33(1):343-4. PubMed ID: 24357057
[No Abstract] [Full Text] [Related]
23. Endoscopic diagnosis and treatment of pancreatic neuroendocrine tumors.
Rustagi T; Farrell JJ
J Clin Gastroenterol; 2014; 48(10):837-44. PubMed ID: 24828360
[TBL] [Abstract][Full Text] [Related]
24. [Endoscopic polypectomy in the upper gastrointestinal tract (author's transl)].
Classen M; Zeus J; Demling L
Leber Magen Darm; 1973 Aug; 3(4):163-5. PubMed ID: 4752478
[No Abstract] [Full Text] [Related]
25. GEP-NETS update: a review on surgery of gastro-entero-pancreatic neuroendocrine tumors.
Partelli S; Maurizi A; Tamburrino D; Baldoni A; Polenta V; Crippa S; Falconi M
Eur J Endocrinol; 2014 Oct; 171(4):R153-62. PubMed ID: 24920289
[TBL] [Abstract][Full Text] [Related]
26. [Our experience regarding biologically inactive gastroenteropancreatic neuroendocrine tumors].
Napolitano L; Francomano F; Gargano E; Francione T; Angelucci D; Napolitano AM
Ann Ital Chir; 2001; 72(1):61-4; discussion 65. PubMed ID: 11464498
[TBL] [Abstract][Full Text] [Related]
27. [Clinicopathological characterization of gastro-entero- pancreatic neuroendocrine tumors].
Borka K
Magy Onkol; 2018 Jul; 62(2):90-97. PubMed ID: 30027936
[TBL] [Abstract][Full Text] [Related]
28. New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors.
Phan AT; Kunz PL; Reidy-Lagunes DL
Clin Adv Hematol Oncol; 2015 May; 13(5 Suppl 5):1-18; quiz 1 p following 18. PubMed ID: 26430956
[TBL] [Abstract][Full Text] [Related]
29. Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival.
van Vilsteren FG; Baskin-Bey ES; Nagorney DM; Sanderson SO; Kremers WK; Rosen CB; Gores GJ; Hobday TJ
Liver Transpl; 2006 Mar; 12(3):448-56. PubMed ID: 16498656
[TBL] [Abstract][Full Text] [Related]
30. A Case of Focal Small-cell Neuroendocrine Carcinoma in the Vicinity of the Extrahepatic Bile Duct, Adjacent to an Extensive Biliary Intraepithelial Neoplasm: A Diagnostic Challenge with Major Clinical Implications.
Aigner B; Kornprat P; Schöllnast H; Kasparek AK; Mischinger HJ; Haybaeck J
Anticancer Res; 2015 Sep; 35(9):4821-8. PubMed ID: 26254373
[TBL] [Abstract][Full Text] [Related]
31. [Gastroduodenal and rectal neuroendocrine neoplasms. When endoscopic and when surgical therapy?].
Dralle H
Chirurg; 2016 Apr; 87(4):269-70. PubMed ID: 26860836
[No Abstract] [Full Text] [Related]
32. Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors.
Singh S; Moody L; Chan DL; Metz DC; Strosberg J; Asmis T; Bailey DL; Bergsland E; Brendtro K; Carroll R; Cleary S; Kim M; Kong G; Law C; Lawrence B; McEwan A; McGregor C; Michael M; Pasieka J; Pavlakis N; Pommier R; Soulen M; Wyld D; Segelov E;
JAMA Oncol; 2018 Nov; 4(11):1597-1604. PubMed ID: 30054622
[TBL] [Abstract][Full Text] [Related]
33. DNA methyltransferases 1, 3a, and 3b overexpression and clinical significance in gastroenteropancreatic neuroendocrine tumors.
Rahman MM; Qian ZR; Wang EL; Yoshimoto K; Nakasono M; Sultana R; Yoshida T; Hayashi T; Haba R; Ishida M; Okabe H; Sano T
Hum Pathol; 2010 Aug; 41(8):1069-78. PubMed ID: 20381114
[TBL] [Abstract][Full Text] [Related]
34. Duodenal neuroendocrine neoplasms: a still poorly recognized clinical entity.
Rossi RE; Rausa E; Cavalcoli F; Conte D; Massironi S
Scand J Gastroenterol; 2018; 53(7):835-842. PubMed ID: 29726295
[TBL] [Abstract][Full Text] [Related]
35. Metastatic neuroendocrine pancreatic tumor - Case report.
Radu EC; Saizu AI; Grigorescu RR; Croitoru AE; Gheorghe C
J Med Life; 2018; 11(1):57-61. PubMed ID: 29696066
[No Abstract] [Full Text] [Related]
36. [Diagnosis for the gastroenteropancreatic neuroendocrine tumors].
Komoto I; Imamura M
Nihon Shokakibyo Gakkai Zasshi; 2014 Dec; 111(12):2263-71. PubMed ID: 25482901
[No Abstract] [Full Text] [Related]
37. [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].
Couvelard A; Scoazec JY
Ann Pathol; 2020 Apr; 40(2):120-133. PubMed ID: 32035641
[TBL] [Abstract][Full Text] [Related]
38. Ki-67 Labeling Index Variability Between Surgically Resected Primary and Metastatic Hepatic Lesions of Gastroenteropancreatic Neuroendocrine Neoplasms.
Furukawa T; Ozaka M; Takamatsu M; Takazawa Y; Inamura K; Inoue Y; Mie T; Takeda T; Kanata R; Kasuga A; Matsuyama M; Sasaki T; Takahashi Y; Sasahira N
Int J Surg Pathol; 2021 Aug; 29(5):475-481. PubMed ID: 33543658
[No Abstract] [Full Text] [Related]
39. Detection of pancreatic neuroendocrine tumors: 23 years of experience.
Varas-Lorenzo MJ; Cugat E; Capdevila J; Sánchez-Vizcaíno Mengual E
Rev Gastroenterol Mex (Engl Ed); 2019; 84(1):18-25. PubMed ID: 29858120
[TBL] [Abstract][Full Text] [Related]
40. Reassessing the grade of gastroenteropancreatic neuroendocrine neoplasms.
Klimstra DS
Endocrine; 2016 Jul; 53(1):4-6. PubMed ID: 27150611
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]